White Papers
Learn unique solutions for your particulate problems with NuAire white papers.
-
[White Paper] Part 2: Facility and Engineering Control Design Under USP <800>
Design considerations for creating a Pharmacy USP 800 compliant Hazardous Drug (HD) compounding operation.
-
[White Paper] Ultralow Freezer: Proper Use and Preventative Maintenance
Eight critical preventive maintenance tips for Minus 80 Ultralow Temperature (ULT) Freezers.
-
[White Paper] CO2 Incubator: Proper Use and Preventative Maintenance
This guide will help lab managers understand risks and best practices as they develop training for CO2 incubator users and establish a preventive maintenance program and setup criteria.
-
[White Paper] How to Maximize Centrifuge Performance
Proper use and care on a daily basis remain critical to maximize performance and extend the service life of a laboratory centrifuge.
-
[White Paper] How to Choose Between Infrared and Thermal conductivity CO2 Sensors in Incubators
This paper compares them and examines IR and TC CO2 Sensor technology in CO2 Incubators and what might be best for a given laboratory.
-
[White Paper] How to Perform a Hazardous Drug Risk Assessment in the Compounding Pharmacy
How to Perform a Hazardous Drug Risk Assessment in the Compounding Pharmacy.
-
[White Paper] Direct Heat or Water Jacketed CO2 Incubators
Direct Heat or Water Jacketed CO2 Incubators, select the right cell growth technology for your research application.
-
[White Paper] HEPA versus ULPA Filters
HEPA versus ULPA filters, which makes the most sense in a biosafety cabinet.
-
[White Paper] Use of HEPA Filters in Biosafety Cabinets
Learn about the use of HEPA filters in biosafety cabinets.
-
[White Paper] Workflow Strategies to Minimize Exposure to Hazardous Drugs in the Compounding Pharmacy
Handling hazardous drugs in the compounding pharmacy, per USP chapter <800> guidelines, involves strategic workflow strategies with the goal of minimizing personnel and environmental exposure.
-
[White Paper] USP 800 Gap Analysis, A Business Perspective
USP 800 is going to financially impact your pharmacy’s future business model so this white paper focuses on five important details that define the "why" for considering a capital investment.
-
[White Paper] Can a Class I and Class II BSC be in the same Sterile Hazardous Drug (HD) Room?
USP 800 does not directly address the pre-sterilization process of a sterile preparation creating the question can a class I and a Class II biosafety cabinet be used in the same sterile HD room?
-
[White Paper] Four Questions to Guide Centrifuge Selection
Choosing the correct centrifuge for a particular application can be a daunting task. These four questions answered will guide your selection to pick the perfect centrifuge.
-
[White Paper] When to Replace Your Laboratory Centrifuge
Learn when to replace your aging laboratory centrifuge.
-
[White Paper] Benefits and Risks of Ultraviolet (UV) Light
Learn the benefits and risks of using ultraviolet (UV) light in a biosafety cabinet.
-
[White Paper] Centrifuge Maintenance: Protecting the Investment
Centrifuges must be operated correctly and undergo regular maintenance in order to achieve maximum lifespan.
-
[White Paper] Part 1: Facility and Engineering Control Design Under USP <800>
The focus of this article is to discuss the details for consideration of a good working design of a USP 800 compliant compounding lab.
-
[White Paper] How Long do HEPA Filters Last
Find the answer to the question how long do HEPA filters last in a Biosafety Cabinet.
-
[White Paper] Industry Standards Your Biosafety Cabinet Should Meet
By purchasing BSC's that adhere to Biosafety Cabinet Industry Standards, customers can be confident that they are working with BSC's that meet industry guidelines.
-
[White Paper] Purchasing a Biosafety Cabinet, Who to Involve
As a Principal Investigator learn who you should invovle when purchasing a biosafety cabinet (BSC).
-
Loading More...